Entorhinal Subfield Vulnerability to Neurofibrillary Tangles in Aging and the Preclinical Stage of Alzheimer’s Disease
Manuscript Number:
21-5567R3
Author(s):
Jean C. Augustinack, Samantha Champion, Bruce Fischl, Matthew P. Frosch, Douglas N. Greve, Melanie Lang-Orsini, Josué Llamas-Rodríguez, Jan Oltmer, Natalya Slepneva, Ruopeng Wang, Emily Williams, André J.W. van der Kouwe
Disclosures
Jean C. Augustinack
Nothing to Disclose
Samantha Champion
Nothing to Disclose
Bruce Fischl
Equity:
I am part owner of CorticoMetrics, a small LLC commercializing neuroimaging analysis tools for use in clinical applications
Matthew P. Frosch
Grants
Agency:
Biogen
Dates:
9/2016-9/2026
Agency:
Voyager Therapeutics
Dates:
1/2020-1/2025
Douglas N. Greve
Nothing to Disclose
Melanie Lang-Orsini
Nothing to Disclose
Josué Llamas-Rodríguez
Nothing to Disclose
Jan Oltmer
Nothing to Disclose
Natalya Slepneva
Nothing to Disclose
André J.W. van der Kouwe
Consulting Fees:
Medical Advisory Board of Nous Imaging, Inc., $400/meeting, two or more meetings per year.
Consulting for Nous Imaging, $300/month.
The business of Nous Imaging does not relate to the subject matter of this paper.
Equity:
Unexercised stock options in Nous Imaging, Inc.
Patents/Royalties
I have patents related to MRI methods. They are not licensed and do not relate to the subject matter of this paper.